Sorry for my lack of knowledge but from what im reading the ORR is 9/12 (75%)
if this is true then it is Incredible
i know other Oncology focussed companies would be raving about it
perhaps the more learned amongst us can shed more light on the data collected thus far
i know the sample size is not big (n=12) but results are promising none the less
Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT, page-71
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.003(6.25%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $4.098M | 80.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1984777 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 450000 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |